Literature DB >> 15537847

Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.

M E Onwuamaegbu1, M Henein, A J Coats.   

Abstract

Cachexia is an independent prognostic marker of survival in many chronic diseases including heart failure and malaria. Morbidity and mortality from malaria is high in most of the third world where it presents a very challenging public health problem. Malaria may present in the UK as fever in the returning traveller or as fever in overseas visitors. How and why cachexia develops in malaria in a manner similar to the cachexia of chronic heart failure and the treatment strategies that would alter outcomes in both diseases are discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15537847      PMCID： PMC1743137          DOI： 10.1136/pgmj.2004.020891

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  77 in total

1.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

2.  Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes.

Authors:  P H Pekala; S R Price; C A Horn; B E Hom; J Moss; A Cerami
Journal:  Trans Assoc Am Physicians       Date:  1984

3.  Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.

Authors:  W Doehner; C D Pflaum; M Rauchhaus; I F Godsland; K Egerer; M Cicoira; V G Florea; R Sharma; A P Bolger; A J Coats; S D Anker; C J Strasburger
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

4.  Intravenous immune globulin in the therapy of peripartum cardiomyopathy.

Authors:  B Bozkurt; F S Villaneuva; R Holubkov; T Tokarczyk; R J Alvarez; G A MacGowan; S Murali; W D Rosenblum; A M Feldman; D M McNamara
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

5.  High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

Authors:  M Cicoira; A P Bolger; W Doehner; M Rauchhaus; C Davos; R Sharma; F O Al-Nasser; A J Coats; S D Anker
Journal:  Cytokine       Date:  2001-07-21       Impact factor: 3.861

6.  Surgical treatment of patients with cardiac cachexia. An analysis of factors affecting operative mortality.

Authors:  M Otaki
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

7.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

Review 8.  The pathophysiology of falciparum malaria.

Authors:  Ian A Clark; William B Cowden
Journal:  Pharmacol Ther       Date:  2003-08       Impact factor: 12.310

9.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

10.  Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.

Authors:  L Schofield; F Hackett
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307
View more
  9 in total

1.  Effects of acute Plasmodium falciparum malaria on body weight in children in an endemic area.

Authors:  Akintunde Sowunmi; Grace O Gbotosho; Ahmed A Adedeji; Babasola A Fateye; Morenikeji F Sabitu; Christian T Happi; Fatai A Fehintola
Journal:  Parasitol Res       Date:  2007-02-25       Impact factor: 2.289

2.  Malaria and obesity: obese mice are resistant to cerebral malaria.

Authors:  Vincent Robert; Catherine Bourgouin; Delphine Depoix; Catherine Thouvenot; Marie-Noëlle Lombard; Philippe Grellier
Journal:  Malar J       Date:  2008-05-19       Impact factor: 2.979

3.  Cachexia as a major public health problem: frequent, costly, and deadly.

Authors:  Jerneja Farkas; Stephan von Haehling; Kamyar Kalantar-Zadeh; John E Morley; Stefan D Anker; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-03-29       Impact factor: 12.910

4.  Gonadal steroids negatively modulate oxidative stress in CBA/Ca female mice infected with P. berghei ANKA.

Authors:  Néstor Aarón Mosqueda-Romo; Ana Laura Rodríguez-Morales; Fidel Orlando Buendía-González; Margarita Aguilar-Sánchez; Jorge Morales-Montor; Martha Legorreta-Herrera
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 5.  Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment.

Authors:  Cathleen Drescher; Masaaki Konishi; Nicole Ebner; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-18       Impact factor: 12.910

6.  Asiatic acid influences parasitaemia reduction and ameliorates malaria anaemia in P. berghei infected Sprague-Dawley male rats.

Authors:  G A Mavondo; B N Mkhwananzi; M V Mabandla; C T Musabayane
Journal:  BMC Complement Altern Med       Date:  2016-09-13       Impact factor: 3.659

7.  Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial.

Authors:  Philip C Calder; Alessandro Laviano; Fredrik Lonnqvist; Maurizio Muscaritoli; Maria Öhlander; Annemie Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-09-10       Impact factor: 12.910

Review 8.  Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?

Authors:  Anna Jaśkiewicz; Tomasz Domoradzki; Beata Pająk
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

Review 9.  Metabolomics as an Important Tool for Determining the Mechanisms of Human Skeletal Muscle Deconditioning.

Authors:  Isabelle Alldritt; Paul L Greenhaff; Daniel J Wilkinson
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 6.208
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.